Community/Retail

Dispensing naloxone provides an example of how small changes can make a significant difference.

Lisa Schwartz, PharmD, RPh, senior director of Professional Affairs at NCPA, discusses the Drug Supply Chain Security Act and why it was updated for the distribution of naloxone.

Loosened restrictions will likely create a more pronounced influenza season this fall.

CDC Director Rochelle Walensky, MD, MPH, announced new preferential flu vaccine recommendations for individuals aged 65 years and older.

Respiratory infections have been associated with onset of type 1 diabetes in previous research, but this risk was notably higher among those with COVID-19 in this study.

As pharmacy moves in the direction of patient-centered care, immunization plays a key role in this shift.

Kurt Proctor, PhD, RPh, senior vice president of strategic initiatives at NCPA, discussed the importance of continue education for pharmacists.

With a trained representative focused on building relationships with prescribers in the community, pharmacies have the opportunity to significantly expand how they do business.

Through gamification and food-focused activities, pharmacists can incentivize patient engagement in these services, even if offered outside the pharmacy.

Kyle McCormick, PharmD, owner of Blueberry Pharmacy, discusses the differences between a traditional pharmacy model and a cost-plus pharmacy model.

As pharmacy conglomerates race toward controlling patient journey, community pharmacist role remains murky.

October is a time to acknowledge the powerful impact pharmacists and pharmacy technicians make on patients and communities.

Tripp Logan, PharmD, vice president at SEMO Rx Pharmacies and Logan & Seiler Inc discusses how pharmacy staff and community health care workers can work together to address social determinants of health.

Bri Morris, PharmD, senior director of Education and the Long-Term Care Division at the National Community Pharmacists Association, discusses the importance of teamwork in the pharmacy.

The history of targeting neuroinflammation is a good example of the challenges to finding a treatment for Alzheimer disease.

Motivational interviewing is an evidence-based method of communicating with patients who are ambivalent or resistant to change for the sake of their health.

The value proposition for point-of-care testing in the pharmacy is extensive, as pharmacies can provide a convenient, accessible, and cost-saving alternative for patients.

Women Pharmacist Day takes place October 12th, 2022.

Teva Pharmaceutical Industries announced that fremanezumab can successfully reduce 2 common migraine comorbid symptoms—anxiety and depression.

As individuals in a society, all people have implicit, or unconscious, beliefs that they have been socialized to hold; however, health care professionals’ implicit biases can impact patients’ lives.

Pharmacy Times will be spotlighting pharmacists throughout the month of October to recognize their contributions to the health care field.

Phoenix-area Walgreens pharmacist Matthew Pruitt earns top honor as 2022 Pharmacist of the Year.

Empagliflozin has been found to lower the risk of death due to cardiovascular events and the number of first and recurrent heart failure hospitalizations.

Indicated for the management of mild, moderate, and severe Alzheimer disease and dementia symptoms, the donepezil transdermal system (Adlarity; Corium) delivers donepezil hydrocholoride through the skin and is recommended at an initial dosage of 5 mg per day.

Douglas Hoey, CEO of NCPA, discusses NCPA's Annual Convention 2022, which will be held in Kansas City, Missouri from October 1 to October 4.

This month's generic product news features clorazepate dipotassium tablets, exemestane tablets, and paliperidone extended-release tablets.

Willoughby hopes on a global standpoint that every chronic condition patient has access to a support team that is there to provide care.

The incremental use of drug combinations could prevent hospitalizations from heart failure among those who have higher ejection farction, a subgroup that struggles with insufficient data on treatments.